Albert Seymour - Feb 23, 2023 Form 4 Insider Report for Homology Medicines, Inc. (FIXX)

Role
President and Chief Executive Officer, Director
Signature
/s/ Paul Alloway, Attorney-in-Fact for Albert Seymour
Stock symbol
FIXX
Transactions as of
Feb 23, 2023
Transactions value $
$0
Form type
4
Date filed
2/27/2023, 03:05 PM
Previous filing
Jan 20, 2023
Next filing
Sep 8, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FIXX Employee Stock Option (Right to Buy) Award $0 +632K $0.00 632K Feb 23, 2023 Common Stock 632K $1.60 Direct F1
transaction FIXX Restricted Stock Units Award $0 +105K $0.00 105K Feb 23, 2023 Common Stock 105K Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests in 48 substantially equal monthly installments upon the Reporting Person's completion of each full month of service following January 1, 2023.
F2 Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. The restricted stock units have no expiration date.
F3 The restricted stock units will vest and settle as to one third of the restricted stock units on each of the first three anniversaries of January 1, 2023 so that such RSUs will become fully vested on January 1, 2026.

Remarks:

President and Chief Executive Officer